← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Tollwut-Immunglobulin vom Menschen currently has availability issues reported in 1 European register: Germany.
Shortage ATC J06BB05 · also listed as: Tollwut-Immunglobulin vom Menschen · data refreshed 23 September 2026
As of 23 September 2026, 1 of the 10 tracked registers list current availability issues for Tollwut-Immunglobulin vom Menschen, covering 1 affected product presentation. Where agencies state a cause, unexpectedly high demand lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-10-31; the earliest is 2026-10-31. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Tollwut-Immunglobulin vom Menschen is coded J06BB05 — a medicine acting on anti-infectives for systemic use — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Berirab | 2026-09-18 | 2026-10-31 | Erhöhte Nachfrage Alternatives: N/A | register ↗ |
Every individual register entry for Tollwut-Immunglobulin vom Menschen in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | Berirab | Shortage | 2026-09-18 | 2026-10-31 | Erhöhte Nachfrage |
Yes. As of 23 September 2026, availability issues are reported in: Germany. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-31 to 2026-10-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Tollwut-Immunglobulin vom Menschen: BfArM (Germany). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Tollwut-Immunglobulin vom Menschen — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/tollwut-immunglobulin-vom-menschen/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Tollwut-Immunglobulin vom Menschen availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/tollwut-immunglobulin-vom-menschen/">Tollwut-Immunglobulin vom Menschen shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>